A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(ii) metallo-intercalator.
A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(ii) metallo-intercalator.
复制标题
DOI:
10.1039/c7sc03712k
复制
发表时间:
2018-01-28
期刊:
影响因子:
8.4
通讯作者:
Vallis KA
中科院分区:
文献类型:
--
作者:
Gill MR;Jarman PJ;Halder S;Walker MG;Saeed HK;Thomas JA;Smythe C;Ramadan K;Vallis KA
[Ru(phen)2(tpphz)]2+ simultaneously inhibits DNA replication, blocks mitosis and enhances DNA-damaging ionising radiation in oesophageal cancer cells. Substitutionally inert ruthenium(ii) polypyridyl complexes have been developed as DNA intercalating agents yet cellular DNA damage responses to this binding modality are largely unexplored. Here, we show the nuclear-targeting complex [Ru(phen)2(tpphz)]2+ (phen = 1,10-phenanthroline, tpphz = tetrapyridophenazine) generates rapid and pronounced stalling of replication fork progression in p53-deficient human oesophageal cancer cells. In response, replication stress and double-strand break (DSB) DNA damage response (DDR) pathways are activated and cell proliferation is inhibited by growth arrest. Moreover, mitotic progression is compromised by [Ru(phen)2(tpphz)]2+, where the generation of metaphase chromosome spindle attachment failure results in spindle assembly checkpoint (SAC) activation. This dual mechanism of action results in preferential growth inhibition of rapidly-proliferating oesophageal cancer cells with elevated mitotic indices. In addition to these single-agent effects, [Ru(phen)2(tpphz)]2+ functions as a radiosensitizer with efficiency comparable to cisplatin, which occurs through a synergistic enhancement of DNA damage. These results establish that DNA replication is the target for [Ru(phen)2(tpphz)]2+ and provide the first experimental evidence that ruthenium-based intercalation targets multiple genome integrity pathways in cancer cells, thereby achieving enhanced selectivity compared to existing DNA-damaging agents such as cisplatin.
登录
查看更多内容
影响因子:
4
作者:
Campisi, Judith
通讯作者:
Campisi, Judith
影响因子:
8.4
作者:
Griffith C;Dayoub AS;Jaranatne T;Alatrash N;Mohamedi A;Abayan K;Breitbach ZS;Armstrong DW;MacDonnell FM
通讯作者:
MacDonnell FM
影响因子:
4.6
作者:
Chen, Tianfeng;Liu, Yanan;Wong, Yum-Shing
通讯作者:
Wong, Yum-Shing
影响因子:
3.5
作者:
Lawrence, TS;Blackstock, AW;McGinn, C
通讯作者:
McGinn, C
影响因子:
11.2
作者:
Koh, Siang-Boon;Courtin, Aurelie;Jodrell, Duncan I.
通讯作者:
Jodrell, Duncan I.